Tom Malinowski sold MiMedx Group Inc (NASDAQ: MDXG)
Tom Malinowski (D-NJ), a U.S. Representative, has disclosed 1 trade in MiMedx Group Inc (MDXG) since 2019, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Tom Malinowski sold $15,001 - $50,000 of MiMedx Group Inc (NASDAQ: MDXG) on May 30, 2019. Since that trade, MDXG is down -6.21% against the S&P 500 up +190.21%, an outperformance of -196.42%.
Data updated
Tom Malinowski's MDXG trades vs the price
MDXG is down -6.21% since Tom Malinowski sold on May 30, 2019, versus +190.21% for the S&P 500.
Performance since this trade
All Tom Malinowski MDXG trades
Tom Malinowski & MDXG trading FAQ
Is it legal for Tom Malinowski to trade MiMedx Group Inc (MDXG) stock?
Yes. Members of Congress are allowed to trade individual stocks, including MiMedx Group Inc (MDXG), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Tom Malinowski sell MDXG?
Tom Malinowski disclosed a sale of $15,001 - $50,000 of MiMedx Group Inc (MDXG) on May 30, 2019, according to public STOCK Act filings.
How has MDXG performed since Tom Malinowski's trade?
Since Tom Malinowski sold MDXG on May 30, 2019, the stock is down -6.21%, versus +190.21% for the S&P 500 over the same period, an outperformance of -196.42%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MDXG trades?
Quantellect tracks every disclosed congressional trade in MiMedx Group Inc (MDXG) on the MiMedx Group Inc congressional trading page, which aggregates filings across all members of Congress.
Tom Malinowski's MDXG tradesAll congressional filings for MiMedx Group IncTom Malinowski's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.